相关实验视频

Updated: Jun 5, 2025

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

在METH诱导的CPP获取上,VTA从NAc核心输入中的胆囊托基宁受体1的调节

Jian Wang¹, Minglong Zhang², Yufei Sun¹

¹College of Forensic Medicine, Hebei Medical University, Hebei Key Laboratory of Forensic Medicine, Collaborative Innovation Center of Forensic Medical Molecular Identification, Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology, Chinese Academy of Medical Sciences, Shijiazhuang, Hebei Province, China.

|December 5, 2024

概括

该研究发现,在VTA-NAcC途径中阻断胆固醇基因因受体1 (CCK1R) 会减少甲基胺成行为. 这突出了CCK1RR.

科学领域:

神经科学是一个神经科学.
成研究研究成研究
分子药理学分子药理学

背景情况:

甲基胺 (METH) 成是一个重要的公共卫生问题.
核心核 (NAcC) 在成中至关重要,GABAergic神经元起着关键作用.
胆囊托基宁 (CCK) 受体与成有关,但它们在METH成电路中的特定功能尚不清楚.

研究的目的:

调查CCK受体亚型在METH诱导成期间在腹膜区域 (VTA) 到NAcC电路中的作用.
为了阐明CCK受体在METH成中的精确神经机制.

主要方法:

建立了一种METH诱导的有条件位置偏好 (CPP) 鼠标模型.
用于CCK受体1 (CCK1R) 和CCK受体2 (CCK2R) 的条件淘汰小鼠.
采用腺相关病毒 (AAV) 来选择性地淘汰VTA-NAcC通路中的CCK受体.

主要成果:

在METH-CPP收购期间,CCK1R而不是CCK2R在NAcC中得到了升级.
在NAcC中CCK1R的遗传删除损害了METH-CPP的获取,并减少了METH诱导的神经元过度兴奋性.
从VTA多巴胺基神经元释放的CCK向NAcCGABAergic神经元.
在VTA^DA →NAcC^GABA电路中的选择性CCK1R淘汰阻止了METH诱导的突触可塑性和突触前释放.

结论:

在VTA^DA →NAcC^GABA电路中的CCK1R对于METH诱导的CPP获取至关重要.
这些发现提供了对CCK受体参与METH成机制的更深入的理解.

关键词:

胆固醇托基宁受体1 胆固醇托基宁受体1 有条件的地方偏好.甲基胺是一种甲基胺.神经元刺激性的神经元刺激性核积累了核心的核心.突触性可塑性突触性可塑性

更多相关视频

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice

Published on: February 18, 2016

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

相关概念视频

Drugs Acting on Autonomic Ganglia: Stimulants

Drugs Acting on Autonomic Ganglia: Stimulants

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...

Adrenergic Agonists: Indirect-Acting Agents

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...